Clinical Trial Update: A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma [Phase 2]

View source ↗

Summary

Phase 2 randomized study of Latanoprost PPDS in ocular hypertension or open-angle glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Latanoprost PPDS (latanoprost)

Snippet

Sponsor: Mati Therapeutics Inc. | Conditions: Ocular Hypertension, Open-Angle Glaucoma | Phase 2 | Status: COMPLETED